Improvement of in vivo antimicrobial activity of HBcARD peptides by D-arginine replacement

Add time:09/28/2019    Source:infona.pl

We previously identified a novel antimicrobial peptide with a broad spectrum bactericidal activity from human hepatitis B virus (HBV) core protein (HBc) arginine-rich domain (ARD). We compared the antimicrobial activities of HBcARD peptides from different hepadnaviruses which share similar amino acid sequences. In general, mammalian HBcARD peptides exhibited stronger antimicrobial activity than avian peptides. Using the strategy of D-amino acid substitutions, we improved the antimicrobial efficacy of human HBcARD peptide. This D-HBcARD peptide was much more resistant than L-HBcARD peptide to proteolytic degradation in vitro. Moreover, this D-HBcARD peptide maintained similar minimal bactericidal concentrations (MBC) against tested bacteria, and showed very low hemolytic activity. In the Staphylococcus aureus-infected mouse model, this D-HBcARD peptide was more protective than the L-HBcARD peptide. Repeated treatments with either L- or D-HBcARD peptides induced no significant immunogenicity. New derivatives of HBcARD peptides could serve as alternatives to the conventional antibiotics in clinical medicine in the future.

We also recommend Trading Suppliers and Manufacturers of D(-)-Arginine (cas 157-06-2). Pls Click Website Link as below: cas 157-06-2 suppliers

Prev:A mechanism behind the antitumour effect of 6-DIAZO-5-OXO-L-NORLEUCINE (cas 157-03-9) (DON): disruption of mitochondria - release of cytochrome c from mitochondria blocked (see comments)
Next:Reducible Poly(Oligo‐d‐Arginine) as an Efficient Carrier of the Thymidine Kinase Gene in the Intracranial Glioblastoma Animal Model)